Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries(Saint John's Health Center), Robert M. Elashoff(University of California, Los Angeles), Richard Hoefer(Sentara CarePlex Hospital), Patrick Terheyden(Saint John's Health Center), Carlo Riccardo Rossi(University of Padua), Jeffrey D. Wayne(Northwestern University), Rogerio I. Neves(Saint John's Health Center), Heather B. Neuman(University of Wisconsin–Madison), Michael A. Henderson(Peter MacCallum Cancer Centre), Anja Gesierich(University of Michigan), B. Mark Smithers(Saint John's Health Center), Alessandro Testori(Mylan (Switzerland)), Adam C. Berger(Fox Chase Cancer Center), Harald J. Hoekstra(University Medical Center Groningen), Jonathan S. Zager(Moffitt Cancer Center), Douglas B. Johnson(Vanderbilt University), Alastair D. MacKenzie Ross(Guy's and St Thomas' NHS Foundation Trust), Eddy C. Hsueh(Saint Louis University), Peter D. Beitsch(Dallas Surgical Group), Robert H.I. Andtbacka(Huntsman Cancer Institute), John F. Thompson(Melanoma Institute Australia), Tara L. Huston(Stony Brook University Hospital), Maurice Matter(University Hospital of Lausanne), Doreen M. Agnese(Saint John's Health Center), Frances C. Wright(Saint John's Health Center), Edward A. Levine(Atrium Health Wake Forest Baptist), Schlomo Schneebaum(Tel Aviv Sourasky Medical Center), Erwin Schultz(Nuremberg Hospital), Lisa K. Jacobs(Johns Hopkins University), Marc Moncrieff(Norfolk and Norwich University Hospital), Peter Hersey(Royal Prince Alfred Hospital), Tawnya L. Bowles(Intermountain Medical Center), Michel W.J.M. Wouters(The Netherlands Cancer Institute), Steven D. Bines(Rush University Medical Center), Tiina Jahkola(Helsinki University Hospital), Jeffrey M. Farma(Fox Chase Cancer Center), Jeffrey E. Gershenwald(Melanoma Institute Australia), Richard J. Barth(Dartmouth–Hitchcock Medical Center), Kelly M. McMasters(University of Louisville), Reinhard Dummer(University of Zurich), Michael S. Sabel(University of Michigan), Christian Ingvar(Lund University), Gregory McKinnon(Saint John's Health Center), Darius C. Desai(St. Luke's University Health Network), David R. Byrd(University of Washington), Steven D. Trocha(Thomas Jefferson University), Alistair J. Cochran(Western Infirmary), Sergi Vidal‐Sicart(Hospital Clínic de Barcelona), Nicola Mozzillo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center), John M. Kane(Hofstra University)
Cited by 1,379
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k